NCT01806116
Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation treatment 4 unknown_status NCT03473457
CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment Not Available terminated NCT06549790
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 1 recruiting NCT02665143
A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia treatment 2 completed NCT05332054
Long-Term Follow-up Study No drug interventions Not Available Not Available enrolling_by_invitation NCT06541405
Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 0 recruiting NCT03190278
Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 1 recruiting NCT05548088
LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 1 unknown_status NCT03318016
Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia treatment 1 terminated NCT03886831
A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies No drug interventions treatment 1 completed NCT06541444
Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 0 recruiting NCT03904069
Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML treatment 1 withdrawn NCT05061147
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) treatment 1 / 2 unknown_status NCT05722171
Clinical Study of UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 0 recruiting NCT05731219
UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 1 recruiting NCT06084819
Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia treatment 2 recruiting NCT05518357
LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 1 completed NCT05627466
US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid Leukemia Not Available Not Available no_longer_available NCT03504410
Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML treatment 3 terminated NCT03541369
Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 1 terminated NCT06049667
A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies No drug interventions treatment 1 recruiting NCT02626338
Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML treatment 1 / 2 completed NCT05143996
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) No drug interventions treatment 1 recruiting NCT05662904
Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients With AML treatment 1 not_yet_recruiting NCT05951855
Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients treatment 2 recruiting NCT02249091
A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) treatment 2 completed NCT02215629
Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia treatment 1 withdrawn NCT05522192
Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia treatment 1 / 2 recruiting NCT05726110
Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia treatment 3 recruiting NCT04478695
Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia treatment 1 terminated NCT03755154
Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia treatment 1 completed NCT04176393
A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation treatment 1 completed NCT02675452
AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia treatment 1 completed NCT05038800
A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002) treatment 1 terminated NCT04842370
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PHI 101 for the Treatment of AML treatment 1 unknown_status NCT04666649
Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) treatment 1 active_not_recruiting NCT03765541
Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia treatment 3 recruiting NCT05787496
A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms No drug interventions treatment 1 recruiting NCT02623582
CD123 Redirected Autologous T Cells for AML treatment 0 terminated NCT05241093
A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) treatment 2 recruiting NCT02074839
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation treatment 1 recruiting NCT05345938
A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia treatment 1 / 2 terminated NCT03218683
Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies. treatment 1 terminated NCT05241106
A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) No drug interventions treatment 2 recruiting NCT04113616
An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML) treatment 1 / 2 terminated